spacer

CDC HomeHIV/AIDS > Topics > Testing > Reports > National HIV Prevalence Surveys, 1997 Summary

National HIV Prevalence Surveys, 1997 Summary
space
arrow Cover
space
arrow Background
space
arrow Summary of Findings
space
arrow Technical Notes
space
arrow Tables
space
arrow Figures
space
arrow Suggested Readings
space
arrow Appendix - Survey of Childbearing Women
space
arrow Appendix - Sentinel Hospital Surveillance System for HIV Infection
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
 
Skip Nav spacer
Suggested Readings
spacer
spacer

General

Bayer R. The ethics of blinded HIV surveillance testing. Am J Public Health 1993;83(4):496-7. CDC. HIV/AIDS Surveillance Report. Atlanta, GA:CDC,1998:10(No.1):1-40.

CDC. National HIV Serosurveillance Summary: Update–1993. Vol. 3. Atlanta, GA: CDC, 1995. Publication HIV/DHAP/6-95-051.

CDC. National HIV Serosurveillance Summary – Results through 1992. Vol. 3. Atlanta, GA: CDC, 1994. Publication HIV/NCID/11-93/036.

CDC. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989;83(No. S-7):1-7.

Dondero TJ, Gill ON. Large-scale HIV serologic surveys: what has been learned? AIDS 1991;5 (suppl 2):S63-S69.

Dondero T, Pappaioanou M, Curran JW. Monitoring the levels and trends of HIV infection: the Public Health Service’s HIV Surveillance Program. Public Health Rep 1988;103:213-20.

Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276: 126-31.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington DC, Government Printing Office, 1988. Publication GPO 887-890.

Pappaioanou M, Dondero TJ, Petersen LR, Onorato IM, Sanchez CD, Curran JW. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep 1990;105:113-9.

Sexually Transmitted Disease Clinics

McCray E, Onorato IM. Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. J Sex Transm Dis 1992;19:235-41.

Onorato IM, McCray E, Pappaioanou M, et al. HIV seroprevalence surveys in sexually transmitted disease clinics. Public Health Rep 1990;105:119-24.

Weinstock HS, Sidhu J, Gwinn M, Karon J, Petersen LR. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:514-22.

Drug Treatment Centers

Allen DM, Onorato IM, Green TA. HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. Am J Public Health 1992;82: 541-6.

Jones TS, Allen DM, Onorato IM, Petersen LR, Dondero TJ, Pappaioanou M. HIV seroprevalence surveys in drug treatment centers. Public Health Rep 1990;105:125-30.

Prevots DR, Allen DM, Lehman JS, Green TA, Petersen LR, Gwinn M. Trends in human immunodeficiency virus seroprevalence among injecting drug users entering drug treatment centers, United States, 1988-93. Am J Epidemiol 1996; 143:733-42.

Adolescent Medicine Clinics

Lindegren ML, Hansen C, Miller K, Byers RH, Onorato IM. Epidemiology of human immunodeficiency virus infection in adolescents, United States. Pediatr Infect Dis J 1994;13:525-35.

Sweeney P, Lindegren ML, Buehler JW, Onorato IM, Janssen RS. Teenagers at risk of human immuno- deficiency virus type 1 infection. Arch Pediatr Adolesc Med 1995;149:521-8.

Wendell DA, Onorato IM, McCray E, Allen DM, Sweeney PA. Youth at risk: sex, drugs, and human immunodeficiency virus. Am J Dis Child 1992;146: 76-81.

Job Corps Entrants

Conway GA, Epstein MR, Hayman CR, et al. Trends in HIV prevalence among disadvantaged youth: survey results from a national job training program, 1988 through 1992. JAMA 1993;269:2887-9.

St. Louis ME, Conway GA, Hayman CR, Miller C, Petersen LR, Dondero TJ. Human immunodeficiency virus infection in disadvantaged adolescents: findings from the US Job Corps. JAMA 1991;266:2387-91.

Valleroy LA, MacKellar DA, Karon JM, Janssen RS, Hayman CR. HIV infection in disadvantaged out-of- school youth: prevalence for U.S. Job Corps entrants, 1990 through 1996. J Acquired Immune Defic Syndr Hum Retrovirol 1998;19:67-73.

Applicants for Military Service

Burke DS, Brundage JF, Goldenbaum M, et al. Human immunodeficiency virus infections in teenagers: seroprevalence among applicants for military service. JAMA 1990;263:2074-7.

Brundage JF, Burke DS, Gardner LI, et al. Tracking the spread of the HIV infection epidemic among young adults in the US: results of the first four years of screening among civilian applicants for military service. J Acquir Immune Defic Syndr 1990;3:1168-80.

spacer
Last Modified: August 9, 2007
Last Reviewed: December 28, 1998
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services